Year of Establishment: 2021

Total Assets(USD):

Total Number of Staff:

Main Competitive Advantages: International Approvals/Standards,Contract Manufacturing (CRO,CMO),Reputation,Quality Service

Other Competitive Advantages: KRB Consulting is a professional company operating in the pharmaceutical business engaged in providing services to the global industry peers, especially qualified and experienced in regulatory affairs, GxP compliance, market access and related services. Our goal is to accelerate the regulatory approval for a fast market access with our tailored and cost-friendly solution for each project. In recent 10 years, KRB has successfully supported for 100+ China APIs and FDFs Pharma in their global market access and GMP inspection activities, continuously promote the internationalization for Chinese pharmaceuticals; Likewise, KRB successfully supported for 50+ overseas Pharma for their products registration and GMP inspection in China mainland. Our goal is to bring sustaining benefits to our customers by the robust services, and promote the compliance for the industry. 金瑞博咨詢是一家專業(yè)從事藥品合規(guī)咨詢的公司，專注于為全球制藥企業(yè)提供藥品注冊事務、GxP合規(guī)、市場準入及相關服務，通過為每個項目量身定制落地且具有成本效益的解決方案，以助力項目高效獲得監(jiān)管批準，快速實現國際市場準入。 近10年以來，金瑞博已幫助中國100+制劑和原料藥企業(yè)實現了在發(fā)達國家的市場準入及GMP核查，持續(xù)助力中國制藥企業(yè)的國際化進程；同時也幫助50+境外企業(yè)實現了在中國的市場準入及順利通過中國海外核查。我們的目標是通過不斷提高服務質量，使我們的客戶得到切實提升和收益，推動整個制藥行業(yè)的持續(xù)合規(guī)。

Patents and Copyrights: